Legal & General Group Plc lifted its stake in shares of Genpact Limited (NYSE:G - Free Report) by 77.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 333,333 shares of the business services provider's stock after purchasing an additional 145,112 shares during the quarter. Legal & General Group Plc owned 0.19% of Genpact worth $14,317,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. SRH Advisors LLC acquired a new stake in Genpact during the 4th quarter valued at approximately $26,000. Atlas Capital Advisors Inc. lifted its holdings in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after buying an additional 216 shares during the period. Manchester Capital Management LLC acquired a new stake in Genpact during the 4th quarter worth about $38,000. Smartleaf Asset Management LLC lifted its stake in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares during the period. Finally, UMB Bank n.a. grew its stake in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.80% of the company's stock.
Genpact Price Performance
NYSE:G traded down $0.17 during mid-day trading on Friday, hitting $47.56. 903,667 shares of the stock traded hands, compared to its average volume of 1,347,126. The business's 50-day moving average price is $50.52 and its 200 day moving average price is $46.04. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The company has a market cap of $8.35 billion, a PE ratio of 16.75, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a dividend of $0.17 per share. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.43%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is currently 23.94%.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on the company. Mizuho upped their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and increased their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Needham & Company LLC upped their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $48.44.
Check Out Our Latest Stock Analysis on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.